January - June 2008
Companies are listed in alphabetical order
1 January – 30 June 2008
- Abbott Australasia
340k - Actelion 24k
- Alcon Pharmaceuticals 21k
- Allergan 46k
- Alphapharm 101k
- AMGEN Australia 187k
- Astrazeneca 352k
- Baxter Healthcare 282k
- Bayer Australia 177k
- Biogen Idec Australia 158k
- Boehringer Ingelheim 158k
- Bristol-Myers Squibb Australia 63k
- Celgene Pty Ltd 9k
- CSL Limited 79k
- Eli Lilly Australia 279k
- Genzyme Australasia Pty Ltd 36k
- Gilead Sciences 46k
- GlaxoSmithKline Australia 158k
- Innovex 23k
- Ipsen 56k
- Janssen-Cilag 173k
- Lundbeck 62k
- Merck Serono 68k
- Merck Sharp & Dohme 127k
- Mundipharma 93k
- Norgine 21k
- Novartis 192k
- Novo Nordisk 227k
- Nycomed 44k
- Organon 90k
- Pfizer 219k
- Roche Products 212k
- sanofi-aventis Part A 7642k & Part B 7564k
- Sanofi Pasteur 24k
- Schering-Plough 182k
- Servier Laboratories 225k
- Smith & Nephew 8k
- Solvay Pharmaceuticals 33k
- UCB Pharma 119k
- Wyeth 130k
Previous Educational Event Reports
Page updated: December 2011